欧耐施HONEST品牌怎么样 申请店铺

我要投票 欧耐施HONEST在饲料添加剂行业中的票数:86 更新时间:2025-02-06
欧耐施HONEST是哪个国家的品牌?「欧耐施HONEST」是 上海欧耐施生物技术有限公司 旗下著名品牌。该品牌发源于上海市,由创始人顾 * 松在2008年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
欧耐施HONEST怎么样


上海欧耐施生物技术有限公司(简称“上海欧耐施”)成立于2008年9月,是一家专业从事饲料酶制剂应用研发、非发酵核心原酶生产、酶制剂及预混料销售高新技术企业。目前现有在职员工45名,其中研究生以上学历10名,博士学历3名。2015年获得上海市高新技术企业,2016年被评为上海市质量示范企业,至2016年12月31日,已获得授权国家发明专利5项,实用新型专利2项。

上海欧耐施的经营模式是构建饲料酶应用开发平台,生产非发酵类核心原酶,专注客户细分化需求,成为饲料酶制剂领域应用专家,为广大客户提供有效而优质产品解决方案。

上海欧耐施秉承“诚信、专业、创新、合作”的企业经营理念,注重实效、关注环保,靠产品品质占领市场、以优质服务回报市场,客户理念是“永远为客户省一点”。

上海欧耐施经过八年持续研究与开发,确立了以开发非发酵类核心原酶为公司发展核心动力,2016年9月在江苏设立了常州欧耐施生物技术有限公司(以下简称“常州欧耐施”),常州欧耐施主要开发蛋白酵素MP(一种有别于市场微生物发酵的特殊功能蛋白酶),年产蛋白酵素MP三千吨左右,目前已经获得一项国家发明专利,另外3项相关发明专利在申请中。

上海欧耐施开发酶制剂的四级应用研发体系,即实验室体外消化评价体系(模型建立)、类SPF肉鸡和猪生物学评价(小型试验)、规模饲料生产和养殖企业评价(中试应用)以及第三方独立性试验评价。公司已与中国农业大学、山东农业大学、河南农业大学、东华大学和上海应用技术大学等国内高校开展合作。

经公司研发平台业已开发了饲料酶应用专家系统(FEAEs),下设常用饲料数据库、酶制剂数据库和环境影响因子数据库,并建立了一套饲用酶制剂评价和研发程序,为国内大型饲料企业和养殖集团定制饲用酶制剂产品方案提供依据。


Shanghai Ornish Biotechnology Co., Ltd. (hereinafter referred to as "Shanghai Ornish") was established in September 2008. It is a high-tech enterprise specializing in the application research and development of feed enzyme preparation, non fermentation core enzyme production, enzyme preparation and premix sales. At present, there are 45 on-the-job employees, including 10 with graduate degree or above and 3 with doctoral degree. In 2015, it was awarded Shanghai high-tech enterprise and Shanghai quality demonstration enterprise in 2016. By December 31, 2016, it has obtained 5 national invention patents and 2 utility model patents. Shanghai onashi's business model is to build a feed enzyme application and development platform, produce non fermentation core protoenzyme, focus on customer demand for fine differentiation, become an application expert in feed enzyme preparation field, and provide customers with effective and high-quality product solutions. Shanghai Ornish adheres to the business philosophy of "integrity, professionalism, innovation and cooperation", pays attention to actual effect and environmental protection, occupies the market by product quality and returns the market by high-quality service. The customer philosophy is "always save a little for customers". After eight years of continuous research and development, Shanghai Ornish has established the development of non fermentative core enzymes as the core driving force for the company's development. In September 2016, Changzhou Ornish Biotechnology Co., Ltd. (hereinafter referred to as "Changzhou Ornish") was established in Jiangsu Province. Changzhou Ornish mainly develops protein enzyme mp (a special functional protease different from market microbial fermentation), with an annual output of The protein enzyme MP is about 3000 tons. At present, it has obtained one national invention patent and another three related invention patents are under application. The four-level application R & D system of enzyme preparation developed by Shanghai Ornish is the evaluation system of laboratory in vitro digestion (model establishment), biological evaluation of SPF like broilers and pigs (small-scale test), evaluation of large-scale feed production and breeding enterprises (pilot application), and evaluation of third-party independence. The company has cooperated with China Agricultural University, Shandong Agricultural University, Henan Agricultural University, Donghua University, Shanghai University of Applied Technology and other domestic universities. The company's R & D platform has developed feed enzyme application expert system (feaes), which consists of common feed database, enzyme preparation database and environmental impact factor database, and has established a set of feed enzyme preparation evaluation and R & D procedures to provide basis for domestic large feed enterprises and breeding groups to customize feed enzyme preparation product scheme.

本文链接: https://brand.waitui.com/3273ad9cf.html 联系电话:021-37820380

千城特选小程序码

7×24h 快讯

美股大型科技股盘前多数下跌,谷歌跌超7%

36氪获悉,美股大型科技股盘前多数下跌,截至发稿,谷歌跌超7%,亚马逊、苹果跌超1%,特斯拉跌0.92%,微软跌0.36%,Meta跌0.35%,奈飞跌0.14%;英伟达涨近1%。

2小时前

热门中概股美股盘前多数走弱,拼多多跌超7%

36氪获悉,热门中概股美股盘前多数走弱,截至发稿,拼多多跌超7%,理想汽车、微博跌超3%,阿里巴巴、京东、百度、蔚来跌超2%,小鹏汽车、爱奇艺跌超1%;B站涨超1%。

2小时前

君实生物:AWT020注射用无菌粉末临床试验申请获批

36氪获悉,君实生物公告,近日,公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,AWT020注射用无菌粉末(项目代号“JS213”)的临床试验申请获得批准。JS213是PD-1和白细胞介素-2双功能性抗体融合蛋白,主要用于晚期恶性肿瘤的治疗。

2小时前

渣打集团任命Maria Ramos接替韦浩思担任集团主席

2月4日,渣打集团董事会宣布,鉴于韦浩思(José Viñals)已接近他服务满9年的任期,已任命Maria Ramos(65岁)接替韦浩思担任集团主席。待取得监管批准后,Maria将于公司在2025年5月8日举行的2025年股东周年大会后履新,而韦浩思届时将自董事会退任。(界面)

2小时前

三六零:公司暂未向DeepSeek提供任何服务

36氪获悉,三六零公告,公司股票于2025年1月24日、1月27日、2月5日连续三个交易日内收盘价格涨幅偏离值累计超过20%,属于股票交易异常波动情形。经自查,公司注意到相关平台将公司股票纳入DeepSeek概念股。公司就相关事项澄清说明如下:在DeepSeek基于MIT开源协议的生态环境下,公司旗下的部分产品进行了DeepSeek的接入与本地化部署;公司暂未向DeepSeek提供任何服务。除上述事项外,公司未发现其他可能对公司股票交易价格产生较大影响的、需要公司澄清或回应的媒体报道或市场传闻

2小时前

本页详细列出关于Novozymes诺维信的品牌信息,含品牌所属公司介绍,Novozymes诺维信所处行业的品牌地位及优势。
咨询